Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.

Proliferative activity, assessed by Ki67 immunohistochemistry (IHC), is an established prognostic and predictive biomarker of breast cancer (BC). However, it remains under-utilized due to lack of standardized robust measurement methodologies and significant intratumor heterogeneity of expression. A...

Descripción completa

Detalles Bibliográficos

Publicado en:	Virchows Archiv: European Journal of Pathology Vol. 468; no. 4; pp. 493 - 503
Autores principales:	Laurinavicius, Arvydas, Plancoulaine, Benoit, Rasmusson, Allan, Besusparis, Justinas, Augulis, Renaldas, Meskauskas, Raimundas, Herlin, Paulette, Laurinaviciene, Aida, Abdelhadi Muftah, Abir, Miligy, Islam, Aleskandarany, Mohammed, Rakha, Emad, Green, Andrew, Ellis, Ian, Abdelhadi Muftah, Abir A, Rakha, Emad A, Green, Andrew R, Ellis, Ian O
Formato:	pictorial research tables/charts Journal Article
Publicado:	Springer Nature Apr2016
Acceso en línea:	Ver este registro en EBSCOhost